Interactions between IL-23 and IL-17 are essential not only for the onset phase, but also for the destruction phase of SLE, which is characterized by the T cell-mediated activation of osteoclastogenesis [19]. The gene discussed is IL17A; the disease is systemic lupus erythematosus.